CLINICAL_TRIALS
trial_result
· 2012-08-03
Clinical Trial Update: Study of Occipital Nerve Stimulation for Drug Refractory Migraine [Phase 2]
Summary
Phase 2 study of occipital nerve stimulation for drug-refractory migraine was terminated; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Migraine | Phase 2 | Status: TERMINATED | Results posted: 2012-08-03